Akari Therapeutics Reports Second Quarter 2019 Financial Results And Highlights Recent Clinical Progress

Ads

You May Also Like

RedHill Biopharma Announces Enrollment of Last Patient in BEKINDA® Phase III Study for Acute Gastroenteritis

 Top-line results are expected in the second quarter of 2017The randomized, double-blind, placebo-controlled Phase III study ...

Genmab to Hold 2017 R&D Update

Media Release R&D Update to be held live in Atlanta, Georgia Key Opinion Leaders ...

Shire plc : Directorate change

Directorate Change Dublin, Ireland - January 19, 2018 - Shire plc (LSE: SHP, NASDAQ: ...